Evidence map›Paper›PMID 19523235›Full record

ArticleBMC cancer2009

Mammographic density and epithelial histopathologic markers.

Martijn Verheus, Gertraud Maskarinec, Eva Erber, Jana S Steude, Jeffrey Killeen, Brenda Y Hernandez, J Mark Cline

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 34 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Association of mammographic and sonographic findings with prognostic molecular factors and hormone receptor expression in malignant breast lesions.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2024
    Article
  5. Article
  6. Review
  7. Article
  8. Review of quantitative multiscale imaging of breast cancer.Journal of medical imaging (Bellingham, Wash.) · 2018
    Review
  9. Involution of breast tissue and mammographic density.Breast cancer research : BCR · 2016
    Article
  10. Article
  11. SEER cancer registry biospecimen research: yesterday and tomorrow.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2014
    Review
  12. Parity and expression of epithelial histopathologic markers in breast tissue.European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) · 2013
    Article
  13. Mammographic breast density response to aromatase inhibition.Clinical cancer research : an official journal of the American Association for Cancer Research · 2013
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Mammographic density and matrix metalloproteinases in breast tissue.Cancer microenvironment : official journal of the International Cancer Microenvironment Society · 2010
    Article
  19. Mammographic density as a predictor of breast cancer outcome.Future oncology (London, England) · 2010
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Martijn VerheusCancer Research Center, University of Hawaii, Honolulu, HI, USA. m.verheus@nki.nl
Gertraud Maskarinec
Eva Erber
Jana S Steude
Jeffrey Killeen
Brenda Y Hernandez
J Mark Cline
University of Hawaiʻi at Mānoa · USUniversity of Hawaii System · USWake Forest University · US

Funding

Multiethnic Cohort Study of Diet and CancerR37CA054281 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI KOLONEL, LAURENCE N. · 2003 to 2012
$23.2M
NESTED CASE CONTROL STUDY OF MAMMOGRAPHIC DENSITYR01CA085265 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI MASKARINEC, GERTRAUD · 2000 to 2002
$728k
NCI NIH HHS R01 CA85265NCI NIH HHS R21 CA1080250NCI NIH HHS R37 CA54281
6 · The paper itself

Abstract

backgroundWe explored the association of mammographic density, a breast cancer risk factor, with hormonal and proliferation markers in benign tissue from tumor blocks of pre-and postmenopausal breast cancer cases.

methodsBreast cancer cases were recruited from a case-control study on breast density. Mammographic density was assessed on digitized prediagnostic mammograms using a computer-assisted method. For 279 participants of the original study, we obtained tumor blocks and prepared tissue microarrays (TMA), but benign tissue cores were only available for 159 women. The TMAs were immunostained for estrogen receptor alpha (ERalpha) and beta (ERbeta), progesterone receptor (PR), HER2/neu, Ki-67, and Proliferating Cell Nuclear Antigen (PCNA). We applied general linear models to compute breast density according to marker expression.

resultsA substantial proportion of the samples were in the low or no staining categories. None of the results was statistically significant, but women with PR and ERbeta staining had 3.4% and 2.4% higher percent density. The respective values for Caucasians were 5.7% and 11.6% but less in Japanese women (3.5% and -1.1%). Percent density was 3.4% higher in women with any Ki-67 staining and 2.2% in those with positive PCNA staining.

conclusionThis study detected little evidence for an association between mammographic density and expression of steroid receptors and proliferation markers in breast tissue, but it illustrated the problems of locating tumor blocks and benign breast tissue samples for epidemiologic research. Given the suggestive findings, future studies examining estrogen effects in tissue, cell proliferation, and density in the breast may be informative.

Indexed as

Gene Expression Regulation, NeoplasticAgedBreast NeoplasmsCell ProliferationErb-b2 Receptor Tyrosine KinasesEstrogen Receptor alphaEstrogen Receptor betaFemaleHumansImmunohistochemistryMammographyMiddle AgedOligonucleotide Array Sequence AnalysisPostmenopausePremenopauseProliferating Cell Nuclear AntigenERBB2 protein, humanErb-b2 Receptor Tyrosine KinasesESR1 protein, humanEstrogen Receptor alphaEstrogen Receptor betaProliferating Cell Nuclear AntigenReceptors, Progesterone

Identifiers

PMID19523235
PMCPMC2709637
OpenAlexW2170116249

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.